Literature DB >> 17954675

Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.

S Keshavjee1, I Y Gelmanova, A D Pasechnikov, S P Mishustin, Y G Andreev, A Yedilbayev, J J Furin, J S Mukherjee, M L Rich, E A Nardell, P E Farmer, J Y Kim, S S Shin.   

Abstract

Tuberculosis (TB) and multidrug-resistant TB (MDR-TB) are diseases of poverty. Because Mycobacterium tuberculosis exists predominantly in a social space often defined by poverty and its comorbidities--overcrowded or congregate living conditions, substance dependence or abuse, and lack of access to proper health services, to name a few--the biology of this organism and of TB drug resistance is intimately linked to the social world in which patients live. This association is demonstrated in Russia, where political changes in the 1990s resulted in increased socioeconomic inequality and a breakdown in health services. The effect on TB and MDR-TB is reflected both in terms of a rise in TB and MDR-TB incidence and increased morbidity and mortality associated with the disease. We present the case example of Tomsk Oblast to delineate how poverty contributed to a growing MDR-TB epidemic and increasing socioeconomic barriers to successful care, even when available. The MDR-TB pilot project implemented in Tomsk addressed both programmatic and socioeconomic factors associated with unfavorable outcomes. The result has been a strengthening of the overall TB control program in the region and improved case-holding for the most vulnerable patients. The model of MDR-TB care in Tomsk is applicable for other resource-poor settings facing challenges to TB and MDR-TB control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954675     DOI: 10.1196/annals.1425.009

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

Review 1.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

2.  The context of ethical problems in medical volunteer work.

Authors:  Anji Wall
Journal:  HEC Forum       Date:  2011-06

3.  Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.

Authors:  M Loveday; K Wallengren; J Brust; J Roberts; A Voce; B Margot; J Ngozo; I Master; G Cassell; N Padayatchi
Journal:  Int J Tuberc Lung Dis       Date:  2015-02       Impact factor: 2.373

4.  Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe.

Authors:  M Mansfeld; A Skrahina; L Shepherd; A Schultze; A M Panteleev; R F Miller; J M Miro; I Zeltina; S Tetradov; H Furrer; O Kirk; A Grzeszczuk; N Bolokadze; A Matteelli; F A Post; J D Lundgren; A Mocroft; Amw Efsen; D N Podlekareva
Journal:  HIV Med       Date:  2015-05-11       Impact factor: 3.180

5.  Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment.

Authors:  Sonya S Shin; Salmaan Keshavjee; Irina Y Gelmanova; Sidney Atwood; Molly F Franke; Sergey P Mishustin; Aivar K Strelis; Yevgeny G Andreev; Alexander D Pasechnikov; Alexander Barnashov; Tamara P Tonkel; Ted Cohen
Journal:  Am J Respir Crit Care Med       Date:  2010-04-22       Impact factor: 21.405

Review 6.  Epidemiology and treatment of multidrug resistant tuberculosis.

Authors:  Carole D Mitnick; Sasha C Appleton; Sonya S Shin
Journal:  Semin Respir Crit Care Med       Date:  2008-09-22       Impact factor: 3.119

7.  Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death.

Authors:  Gustavo E Velásquez; Mercedes C Becerra; Irina Y Gelmanova; Alexander D Pasechnikov; Askar Yedilbayev; Sonya S Shin; Yevgeny G Andreev; Galina Yanova; Sidney S Atwood; Carole D Mitnick; Molly F Franke; Michael L Rich; Salmaan Keshavjee
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

8.  Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis.

Authors:  M T Gler; L J Podewils; N Munez; M Galipot; M I D Quelapio; T E Tupasi
Journal:  Int J Tuberc Lung Dis       Date:  2012-05-07       Impact factor: 2.373

9.  Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints.

Authors:  Stefan Niemann; Claudio U Köser; Sebastien Gagneux; Claudia Plinke; Susanne Homolka; Helen Bignell; Richard J Carter; R Keira Cheetham; Anthony Cox; Niall A Gormley; Paula Kokko-Gonzales; Lisa J Murray; Roberto Rigatti; Vincent P Smith; Felix P M Arends; Helen S Cox; Geoff Smith; John A C Archer
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

10.  Early and efficient detection of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures.

Authors:  Benson R Kidenya; Rodrick Kabangila; Robert N Peck; Stephen E Mshana; Lauren E Webster; Serena P Koenig; Warren D Johnson; Daniel W Fitzgerald
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.